ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers
Clinical trial NCT05616624 · TERMINATED
Trial details
- NCT number
- NCT05616624
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-05
- Primary completion
- 2026-07-22
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.